HLA-DPA1 overexpression inhibits cancer progression, reduces resistance to cisplatin, and correlates with increased immune infiltration in lung adenocarcinoma
Figure 4.The association between a decreased expression of HLA-DPA1 and poor prognosis of patients with LUAD using the LCE database. Abbreviations: LUAD: lung adenocarcinoma; LCE: Lung Cancer Explorer.